Orasure Technologies Inc income statement

In fiscal 2025, Orasure Technologies Inc reported revenue of $115m, down 38.1% on the year before, operating income of −$72.0m (a -62.6% margin) and net income of −$68.7m, or −$0.94 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Orasure Technologies Inc: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	77	75	82	88	99	106	120	128	167	182	155	172	234	387	405	186	115	112
Cost of revenue	—	—	—	—	—	—	—	40	68	68	60	70	116	239	234	106	67	65
Gross profit	47	47	52	56	59	67	80	88	99	114	95	102	118	148	172	79	48	48
Research and development	13	13	18	12	11	12	12	10	13	16	20	31	34	36	34	26	43	45
Selling and marketing	21	21	22	37	46	41	35	30	29	31	32	34	45	49	36	31	26	26
General and administrative	17	17	20	22	22	24	25	28	29	38	35	43	50	68	58	46	48	50
Operating income	−9	−3	−9	−16	−12	−5	8	20	40	28	19	−5	−10	−22	33	−28	−72	−54
Interest expense	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Income before tax	−8	−3	−10	−17	−12	−4	9	20	41	32	21	−4	−9	−16	56	−16	−65	−47
Income tax	−1	—	−1	−1	−1	0	1	1	10	11	5	11	14	1	3	2	2	−0
Net income	−8	−3	−9	−15	−11	−5	8	20	31	20	17	−15	−23	−17	54	−20	−69	−49
Diluted EPS	−$0.17	−$0.08	−$0.19	−$0.29	−$0.20	−$0.08	$0.14	$0.35	$0.51	$0.33	$0.27	$0.22	−$0.32	−$0.24	$0.72	−$0.26	−$0.94	−$0.69
Diluted shares (average)	—	46m	47m	51m	56m	56m	57m	57m	61m	63m	62m	68m	72m	73m	74m	74m	73m	71m
EBITDA	−6	−0	−5	−9	−6	2	14	26	46	35	26	4	1	−7	54	−17	−62	−44

US$ millions unless shown otherwise. Fiscal quarters.

Orasure Technologies Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	40	37	30	31	27	27	28	31
Cost of revenue	23	24	18	18	15	16	16	17
Gross profit	17	14	12	13	12	11	12	13
Research and development	6	6	10	11	10	11	14	9
Selling and marketing	8	7	7	6	6	7	7	7
General and administrative	10	13	14	13	11	10	15	14
Operating income	−6	−12	−18	−18	−16	−20	−23	5
Income before tax	−3	−10	−16	−17	−13	−18	−22	7
Income tax	1	1	−0	2	0	0	−0	0
Net income	−5	−11	−16	−20	−14	−19	−22	6
Diluted EPS	−$0.06	−$0.14	−$0.21	−$0.26	−$0.19	−$0.27	−$0.32	$0.09
EBITDA	−3	−10	−15	−16	−14	−18	−21	8

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MDXG vs OSUR ORGO vs OSUR OSUR vs UFPT NXGL vs OSUR

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Orasure Technologies Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Orasure Technologies Inc.